Delivery Order SPE2DB20D2104-SPE2DB25FNAXW
- Not listed
- The Defense Logistics Agency awarded a $4,345.92 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a non-set-aside award issued through competitive procurement. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $6,130.28 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The contract performs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,567.90 on August 6, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $1,130.90. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a $2,606.15 delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count). This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,818.29 to AmerisourceBergen Drug Corp for the supply of Janumet 50-500 mg tablets (180-count package) on November 5, 2025, with completion scheduled for November 6, 2025. This non-set-aside, competitively awarded contract operates under a firm fixed price structure and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a $10,383.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 21, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count packages) under a firm fixed-price contract valued at $6,537.32. This is a competitive, non-set-aside award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,078.36. This firm fixed-price delivery order, which is not set aside for any specific business category, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is identified as...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAXWDelivery Order
The Defense Logistics Agency awarded a $2,050.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Janumet 50-500 mg tablets (180-count units). The contract, which is non-set-aside and competitively awarded, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. As the prime contractor on the SPE2DX IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The Janumet delivery under this order contributes to the broader pharmaceutical supply chain managed through DLA's Medical Supply Chain, supporting federal healthcare missions with both brand-name and generic medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/18/25 |